3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
10
Prostatic Neoplasms
5
Lymphoma, Non-Hodgkin
4
Colorectal Neoplasms
4
Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Melanoma
3
Leukemia
3
Hematologic Neoplasms
3
Head and Neck Neoplasms
3
Uterine Cervical Neoplasms
2
Ovarian Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Carcinoma, Renal Cell
2
Carcinoma
2
Brain Neoplasms
2
Adenocarcinoma
2
von Hippel-Lindau Disease
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thrombocytopenia
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Hypoxia
×
30 days
×
Clear all
NCT07617038
2026-06-01
HERO
Université de Montréal
Phase NA
Enrolling by invitation
60 enrolled